Sahm Adrangi is only 32 years old but he managed over one hundred and fifty million dollars in July 2017 as chief investment officer and founder of Kerrisdale Capital Management. What may be even more impressive is his brash internet presence, especially on Twitter. Not afraid to call people out for both good and bad, he has swagger in his name-calling and brutal honesty of the observable. He became well known for calling out fraudulent companies and sometimes profiting from it. Some of these companies include China Marine Food Group, Lihua, and China-Biotics. Many times, the companies he calls out end up being subject to investigations and enforcement by various agencies.
Sahm Adrangi graduates from Yale University in 2003 with a Bachelors in Economics. After graduating, Sahm Adrangi worked for Deutsche Bank in the leveraged finance group structuring and syndicating high yield bonds and non-investment grade bank debt. From there he went to Chanin Capital Partners and Longacre Fund Management from 2005 – 2007 and 2007 – 2009. At Longacre he managed a distressed debt fund of two billion dollars.
Adrangi founded the investment management firm Kerrisdale Capital Management in April 2009 with just around one million dollars. He is known for his research on the companies he investigates. He wants to show how these companies actually operate and what their prospects are. In his years with Kerrisdale, Sahm Adrangi focuses on certain areas where he holds a sort of expertise: biotechnology, mining, and telecommunications.
He has a particular knack for predicting huge problems in the biotech field. When Sahm Adrangi shorts a company’s stock around the hype of a new drug, absolute failure is usually sure to follow. In at least one instance it was found that a drug was not any more effective than a placebo, another was a cancer vaccine that failed in the long run.